Sr. Director, Business Development and Corporate Strategy

Overview

Who We Are:

At Dendreon, we’re transforming the battle against cancer with personalized immunotherapy. Our flagship product,
PROVENGE® (sipuleucel‑T), was the first FDA‑approved immunotherapy for metastatic castrate‑resistant prostate cancer, utilizing a patient’s own immune cells to fight the disease.

If you’re driven by the opportunity to make a meaningful impact on cancer patients’ lives, we invite you to join our team. With Immunotherapy Manufacturing Facilities in Seal Beach, CA, and Union City, GA, a strong Research & Development group in Seattle, WA, and a highly skilled Commercial team across the nation, Dendreon is at the forefront of cancer treatment innovation.

Core Values:

• Put Patients First: Every day is an opportunity to improve the lives of those living with cancer.
• Act with Integrity: We commit to transparency, honesty, and always doing what’s right.
• Build Trust: Trust is earned through candid, open communication and a collaborative approach.
• Raise the Bar: We embrace continuous improvement and innovation, always striving to elevate our people.
• Drive Results: We are accountable to each other and deliver success together.

Job Summary:

The Senior Director of Business Development & Corporate Strategy will drive Dendreon’s growth through strategic partnerships, licensing, and corporate development initiatives. This role requires an experienced biotech or pharmaceutical business development leader with a track record of advancing innovative, late‑stage (Phase II/III), first‑in‑class assets. The Senior Director will lead global opportunity sourcing, diligence, and deal execution, while partnering cross‑functionally to evaluate international assets and collaborations, support CDMO business development, and engage with financial investment partners.

Key Responsibilities:

• Strategic Partnerships & Investment‑Driven Growth
  • Serve as a key corporate strategist, identifying high‑impact opportunities for external innovation and investment.
  • Identify, evaluate, and lead strategic transactions and investments aligned with Dendreon’s business strategy, including first‑in‑class and differentiated therapeutic modalities (e.g., ADCs or other complex platforms).
• Biotech Business Development & Asset Acquisition
  • Lead the search, evaluation, and acquisition of innovative clinical‑to‑commercial‑stage therapeutic assets, with emphasis on late‑stage (Phase II/III), first‑in‑class programs aligned with Dendreon’s core therapeutic areas, including immunotherapy, urology, and oncology.
  • Evaluate complex therapeutic modalities, including antibody‑drug conjugates (ADCs) or similarly advanced platforms, assessing scientific differentiation, clinical risk, and commercial potential.
  • Conduct robust diligence with cross‑functional support from Clinical, Regulatory, CMC, IP, Commercial, and Finance to drive informed decisions and maximize asset value.
  • Develop detailed market assessments, forecasts, valuation models, and scenario analyses for internal and external opportunities.
  • Partner closely with internal teams (R&D, Clinical, Regulatory, Commercial, Finance, Legal/IP) to perform scientific and commercial diligence, valuation modeling, and competitive landscape analyses.
• CDMO Strategy & Business Development
  • Build and execute a business development plan to position Dendreon’s manufacturing capabilities as a CDMO partner for emerging and established biotech clients.
  • Identify and engage prospective CDMO partners, from early‑stage startups to mid‑size biotechs, structuring proposals and partnerships that leverage Dendreon’s technical and operational strengths.
  • Collaborate with Technical Operations, Quality, and Regulatory to ensure operational readiness and partner alignment on timelines and technical feasibility.
  • Represent Dendreon at relevant CDMO and manufacturing conferences and in client‑facing discussions.
• Deal Structuring, Negotiation & Execution
  • Lead the structuring, negotiation, and execution of term sheets and definitive agreements for BD and CDMO transactions.
  • Manage internal due diligence processes, coordinate with legal on contract development, and align stakeholders on deal terms and governance.
• Executive…